Polyclonal Antibodies
Anti-IL13RA1 Polyclonal Antibody for WB, ELISA - P78552
Item Number : CM0027921
Price varies based on specs and customizations
- Application
- WB, ELISA
- Cross Reactivity
- Human, Mouse
- Protein Weight
- 49kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | IL13RA1 Rabbit pAb |
| Remarks/Alias | NR4; CT19; CD213A1; IL-13Ra; IL13RA1 |
| Species | Human |
| GeneID (human) | 3597 |
| GeneID | 3597 |
| Immunogen | Recombinant protein | Recombinant fusion protein containing a sequence corresponding to amino acids 29-343 of human IL13RA1 (NP_001551.1). |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, ELISA |
| Cross Reactivity | Human, Mouse |
| SWISS | P78552 |
| Protein Weight | 49kDa |
| Shipping | Ice bag |
Biological Background: IL13RA1 Function and Localization
- Encoded by the IL13RA1 gene, interleukin-13 receptor subunit alpha-1 (also known as CD213A1, NR4, CT19) is a single-pass type I membrane protein and a member of the type I cytokine receptor family.
- Contains a signal peptide, an extracellular domain with fibronectin type-III-like repeats, a transmembrane helix, and a cytoplasmic tail.
- Functions as a low-affinity receptor for interleukin-13 (IL13); upon heterodimerization with IL4RA, forms a high-affinity functional receptor complex that mediates IL13 signaling.
- Additionally serves as an alternate accessory protein for interleukin-4 (IL4) signaling, substituting for the common cytokine receptor gamma chain (IL2RG) but does not enhance interleukin-2 (IL2) binding.
- Ubiquitously expressed with highest levels in heart, liver, skeletal muscle, and ovary; lower levels in brain, lung, and kidney; also detected in B-cells, T-cells, and endothelial cells (relevant to cancer/testis antigen expression).
- Subject to post-translational modifications including N-linked glycosylation and disulfide bond formation, contributing to the observed molecular weight (~49kDa) larger than the calculated 48.8kDa.
Experimental Guidance and Technical Tips
- The immunogen corresponds to the entire extracellular domain (amino acids 29–343) of human IL13RA1, suggesting reactivity with native and recombinant protein; consider using a positive control such as IL13RA1-overexpressing cell lysates or purified recombinant protein.
- For Western blot, a band around 49kDa is expected; due to glycosylation, the apparent molecular weight may vary slightly; optimize blocking and antibody dilution for your system.
- ELISA applications may benefit from pairing with a capture antibody or antigen coating; validate binding in the context of IL13 or IL4 competition if studying receptor-ligand interactions.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio is your one-stop sourcing partner for IVD raw materials, offering a comprehensive range of validated antibodies, including this anti-IL13RA1 polyclonal antibody, to support research into IL13/IL4 signaling, allergy, asthma, and inflammatory diseases. We provide bulk supply, antibody pair development, and rare target sourcing, streamlining your workflow from discovery to diagnostic kit assembly.
Product Datasheet
Anti-IL13RA1 Polyclonal Antibody for WB, ELISA - P78552
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!